Company: CWAN
Filing Date: 2025-03-20
Form Type: 424B3
Source: 0001193125-25-058975
Chunk: 233

Company: Clearwater Analytics Holdings, Inc.
Filing Date: 2025-03-20
Form: 424B3
Chunk 233
---
 | $         |        1.30 |     | 6 | -d |
| Diluted                                                                       |     | $              |        1.68 |     |                |       |     |                  |   |     |             |         |   |     |   |     |     |             |         |   |     | $         |        1.14 |     | 6 | -d |
| Weighted average shares of Common Stock and Class D common stock outstanding: |     |                |             |     |                |       |     |                  |   |     |             |         |   |     |   |     |     |             |         |   |     |           |             |     |   |    |
| Basic                                                                         |     |                | 219,316,625 |     |                |       |     |                  |   |     |             |         |   |     |   |     |     |             |         |   |     |           | 244,600,477 |     | 6 | -d |
| Diluted                                                                       |     |                | 254,362,539 |     |                |       |     |                  |   |     |             |         |   |     |   |     |     |             |         |   |     |           | 281,102,644 |     | 6 | -d |

See accompanying notes to unaudited pro forma condensed combined financial information. 154

NOTES TO UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION

Note 1 Basis of Presentation

The
unaudited pro forma condensed combined financial information is prepared in accordance with Article 11 of Regulation S-X as amended by the final rule, Release
No. 33-10786 “Amendments to Financial Disclosures about Acquired and Disposed Businesses.” The historical information of Clearwater and Enfusion is presented in accordance with accounting
principles generally accepted in the United States of America.

The unaudited pro forma condensed combined balance sheet as of
December 31, 2024 is prepared using Clearwater’s and Enfusion’s audited consolidated balance sheets as of December 31, 2024, giving effect to (i) the Transactions as if it had been completed on December 31, 2024 and
(ii) the assumptions and adjustments described in the accompanying notes to the unaudited pro forma condensed combined financial information.